查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1462761

到 2030 年影像导航放射治疗(IGRT) 市场预测：按产品、技术、应用、最终用户和地区进行的全球分析

Image Guided Radiotherapy Market Forecasts to 2030 - Global Analysis By Product (Software, Hardware, Accessories and Service), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2023年全球影像导航放射治疗（IGRT）市场规模将达20.5亿美元，预测期内复合年增长率为7.2%，预计到2030年将达到33.4亿美元。

影像导航放射治疗（IGRT）是一种精准放射治疗，利用影像技术引导放射线到达肿瘤。 IGRT 使临床医生能够即时观察肿瘤和周围组织，从而更准确地瞄准辐射并最大限度地减少对健康组织的损害。这种方法可以提高治疗效果，同时减少副作用。 IGRT 对于治疗期间移动或位于重要器官附近的肿瘤特别有效，从而改善治疗结果并提高患者安全。

根据美国癌症协会预测，到2040年，全球癌症病例数预计将达到2840万，比2020年增加47%，其中由于人口结构变化，预计增幅最大的是发展中国家，超过60%。癌症患者接受某种形式的放射线治疗作为治疗的一部分。

癌症盛行率上升

随着癌症发病率的增加，对高精度和微创的先进治疗方法的需求不断增长。 IGRT 利用最先进的影像技术，越来越成为癌症治疗的首选选择，因为它可以精确靶向肿瘤，同时保护健康组织。对更有效和量身定制的癌症治疗的需求不断增长，使 IGRT 成为一种关键的解决方案，随着癌症治疗的扩展，推动其采用和市场成长。

缺乏熟练的专业人员

缺乏训练有素的专业人员是影像导航放射治疗（IGRT）市场扩张的主要障碍。 IGRT 技术的成功使用需要熟悉其操作和解释的熟练医疗人员。如果没有足够的劳动力，医疗机构可能难以提供 IGRT 服务，导致 IGRT 技术利用不足并抑制市场成长潜力。

放射治疗设备持续创新

放射治疗设备的持续创新提高了治疗的准确性、效率和患者的治疗效果。改进的显像模式、即时监测和自动治疗输送系统等先进功能提高了肿瘤靶向的精确度，同时最大限度地减少对周围健康组织的损害。这些创新吸引了寻求尖端解决方案并提高采用率的医疗保健提供者。此外，技术进步使得更紧凑、更具成本效益的 IGRT 系统的开发成为可能，从而扩大了患者群体的覆盖范围。

昂贵的设备和治疗费用

IGRT 设备和治疗的高昂成本限制了其可近性，特别是在医疗保健预算有限的地区。 IGRT 系统所需的大量初始投资和持续治疗成本阻碍了医疗机构采用该技术。此外，患者面临经济负担，医疗保健提供者在确保 IGRT 手术报销方面面临挑战。因此，高昂的设备和处理成本阻碍了IGRT的普及和使用，阻碍了市场拓展。

COVID-19 的影响

COVID-19 的爆发对影像导航放射治疗(IGRT) 市场产生了各种影响。最初，医疗设施的关闭和资源的重新调整扰乱了治疗计划，并减缓了新设备的推出，但由于强劲的需求和对癌症护理的日益关注，市场已出现反弹。此外，疫情加速了远端医疗和远端监控技术的采用，这可能对 IGRT 服务的提供和获取方式产生长期影响，从而推动市场成长。

3D超音波产业预计在预测期内成为最大的产业

3D超音波领域预计将出现良好的成长。 3D超音波透过提供肿瘤部位的即时、高解析度成像来提高治疗的精确度和准确度。该技术提供了肿瘤边界和周围解剖结构的更好可视化，使肿瘤学家能够非常精确地定制放射治疗。将其纳入您的 IGRT 工作流程可以改善患者的治疗效果和治疗效果。

预计脑肿瘤领域在预测期内的复合年增长率最高。

预计脑肿瘤领域在预测期内将出现最高的复合年增长率。 IGRT 利用 MRI、CT 和 PET 扫描等先进影像技术即时显示正在治疗的肿瘤并实现精确的放射治疗。这种方法可以提高治疗效果，同时降低副作用的风险。它还有助于根据患者的个别需求制定个人化治疗计划，优化脑肿瘤患者的治疗结果。

比最大的地区

由于癌症发病率增加和医疗基础设施的进步，预计亚太地区在预测期内将占据最大的市场占有率。中国和印度等新兴经济体是主要贡献者，这得益于不断上涨的医疗费用和更多先进治疗方法的机会。由于有利的法规环境和不断提高的癌症治疗意识，亚太地区的 IGRT 市场预计将持续成长。

复合年增长率最高的地区：

由于其高癌症发病率和强大的医疗基础设施，预计欧洲在预测期内将经历最高的复合年增长率。美国凭藉着广泛的研发活动和对医疗保健技术的大量投资主导了市场。先进成像技术和软体解决方案的更多采用以及有利的报销政策正在推动市场扩张。北美 IGRT 市场专注于精准医疗和以患者为中心的护理，有望实现持续成长和技术进步。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球影像导航放射治疗(IGRT) 市场：依产品

  • 软体
    • 治疗计画软体
    • 影像处理软体
    • 影像配准软体
    • 治疗交付软体
    • 品质保证软体
  • 硬体
    • 线性加速器（LINAC）
    • X射线系统
    • 超音波系统
  • 配件
    • IGRT表
    • 伊格特沙发
    • IGRT标记
    • IGRT校准仪
    • IGRT固定装置
  • 服务
    • 安装服务
    • 保养及维修服务

第六章全球影像导航放射治疗(IGRT) 市场：依技术分类

  • 锥状射束扫描 (CBCT)
  • 3D超音波
  • MRI 导引放射治疗 (MRI-RT)
  • 正子断层扫描 (PET) 导引放射治疗 (PET-RT)
  • 电脑断层扫描 (CT) 导引放射治疗 (CT-RT)
  • 其他技术

第七章全球影像导航放射治疗（IGRT）市场：依应用分类

  • 摄护腺癌
  • 乳癌
  • 肺癌
  • 头颈癌
  • 脑肿瘤
  • 妇科癌症
  • 其他用途

第八章全球影像导航放射治疗(IGRT) 市场：依最终使用者分类

  • 医院
  • 放射治疗中心
  • 癌症研究所
  • 其他最终用户

第九章全球影像导航放射治疗（IGRT）市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Siemens Healthineers
  • Elekta AB
  • Accuray Incorporated
  • ViewRay, Inc.
  • Brainlab AG
  • RaySearch Laboratories
  • Mevion Medical Systems
  • C-RAD AB
  • IBA Dosimetry GmbH
  • Philips Healthcare
  • Hitachi Medical Systems
  • Theragenics Corporation
  • Nanobiotix
  • Xstrahl Limited
Product Code: SMRC25812

According to Stratistics MRC, the Global Image Guided Radiotherapy Market is accounted for $2.05 billion in 2023 and is expected to reach $3.34 billion by 2030 growing at a CAGR of 7.2% during the forecast period. Image Guided Radiotherapy (IGRT) is a precise form of radiation therapy that utilizes imaging technology to guide the delivery of radiation to tumours. IGRT enables clinicians to visualize the tumor and surrounding tissues in real-time, allowing for more accurate targeting of radiation and minimizing damage to healthy tissue. This approach enhances treatment effectiveness while reducing side effects. IGRT is particularly valuable for tumours that move during treatment or are located near critical organs, offering improved outcomes and increased patient safety.

According to the American Cancer Society, the burden of cancer worldwide is expected to reach ~28.4 million cases by 2040, increased by 47% from 2020, with greater increases in developing countries due to demographic changes and over 60% of cancer patients undergo some form of radiation therapy as part of their treatment.

Market Dynamics:

Driver:

Rising prevalence of cancer

With cancer incidence rates on the rise, there's an amplified demand for advanced treatment modalities that offer precision and minimal invasiveness. IGRT, leveraging cutting-edge imaging technologies, enables precise tumor targeting while sparing healthy tissues, making it an increasingly preferred option in oncology. This growing demand for more effective and tailored cancer treatments positions IGRT as a pivotal solution, driving its adoption and market growth amidst the expanding landscape of cancer care.

Restraint:

Lack of skilled professionals

The scarcity of trained professionals poses a significant obstacle to the expansion of the Image Guided Radiotherapy (IGRT) market. Successful utilization of IGRT technology necessitates skilled healthcare practitioners proficient in its operation and interpretation. Without an adequate workforce, healthcare facilities may struggle to offer IGRT services, leading to underutilization of IGRT technology and hindering its market growth potential.

Opportunity:

Continuous innovations in radiotherapy equipment

Continuous innovations in radiotherapy equipment enhance treatment precision, efficiency, and patient outcomes. Advanced features such as improved imaging modalities, real-time monitoring, and automated treatment delivery systems increase the accuracy of tumor targeting while minimizing damage to surrounding healthy tissue. These innovations attract healthcare providers seeking state-of-the-art solutions, boosting adoption rates. Additionally, technological advancements enable the development of more compact and cost-effective IGRT systems, expanding accessibility to a broader patient population.

Threat:

High cost of equipment and treatment

The high cost of equipment and treatment in IGRT limits accessibility, particularly in regions with constrained healthcare budgets. The substantial initial investment required for IGRT systems and ongoing treatment expenses can deter healthcare facilities from adopting this technology. Additionally, patients face financial burdens, and healthcare providers encounters challenges in securing reimbursement for IGRT procedures. Consequently, the high cost of equipment and treatment hampers the widespread adoption and utilization of IGRT, impeding market expansion.

Covid-19 Impact

The covid-19 pandemic has had a mixed impact on the image guided radiotherapy market. While it initially led to disruptions in treatment schedules and a slowdown in installations of new equipment due to healthcare facility closures and reprioritization of resources, there has been a subsequent rebound driven by pent-up demand and a growing emphasis on cancer care. Furthermore, the pandemic has accelerated the adoption of telemedicine and remote monitoring technologies, which could have long-term implications for how IGRT services are delivered and accessed, potentially fostering market growth.

The 3D ultrasound segment is expected to be the largest during the forecast period

The 3D ultrasound segment is estimated to have a lucrative growth. By providing real-time, high-resolution imaging of tumor sites, 3D ultrasound enhances the precision and accuracy of treatment delivery. This technology allows for better visualization of tumor boundaries and surrounding anatomy, enabling oncologists to tailor radiation therapy with utmost precision. Its incorporation into IGRT workflows enhances patient outcomes and treatment efficacy.

The brain tumours segment is expected to have the highest CAGR during the forecast period

The brain tumours segment is anticipated to witness the highest CAGR growth during the forecast period. Utilizing advanced imaging techniques such as MRI, CT, and PET scans, IGRT enables real-time visualization of tumours during treatment, allowing for accurate radiation delivery. This approach enhances treatment efficacy while reducing the risk of side effects. It also facilitates personalized treatment plans tailored to individual patient needs, optimizing outcomes for brain tumor patients.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to increasing cancer incidence and advancements in healthcare infrastructure. Emerging economies such as China and India are key contributors, supported by rising healthcare expenditure and expanding access to advanced treatment modalities. With a favourable regulatory environment and growing awareness about cancer care, the Asia Pacific IGRT market is poised for continued growth.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to high prevalence of cancer and robust healthcare infrastructure. The United States dominates the market, driven by extensive research and development activities, along with significant investments in healthcare technology. Increasing adoption of advanced imaging technologies and software solutions, coupled with favourable reimbursement policies, propels market expansion. With a focus on precision medicine and patient-centric care, the North American IGRT market is poised for sustained growth and technological advancements.

Key players in the market

Some of the key players profiled in the Image Guided Radiotherapy Market include Siemens Healthineers, Elekta AB, Accuray Incorporated, ViewRay, Inc., Brainlab AG, RaySearch Laboratories, Mevion Medical Systems, C-RAD AB, IBA Dosimetry GmbH, Philips Healthcare, Hitachi Medical Systems, Theragenics Corporation, Nanobiotix and Xstrahl Limited.

Key Developments:

In March 2024, Siemens Healthineers and Varian Medical Systems announced the launch of their Image Guided Radiotherapy (IGR) product. The product helps practitioners provide digital image data for diagnosis, risk stratification, and treatment planning in the early stages of liver cancer detection. The data can also provide guidance and support during care.

In February 2024, Royal Philips, a health technology company, announced the launch of the Azurion neuro biplane system, a new version of its Image Guided Therapy (IGT) platform. The Azurion platform is powered by ConnectOS, a new operating system from Philips that optimizes system integration.

Products Covered:

  • Software
  • Hardware
  • Accessories
  • Service

Technologies Covered:

  • Cone Beam Computed Tomography (CBCT)
  • 3D Ultrasound
  • MRI-guided Radiation Therapy (MRI-RT)
  • Positron Emission Tomography (PET) -guided Radiation Therapy (PET-RT)
  • Computed Tomography (CT) -guided Radiation Therapy (CT-RT)
  • Other Technologies

Applications Covered:

  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head and Neck Cancer
  • Brain Tumours
  • Gynaecological Cancer
  • Other Applications

End Users Covered:

  • Hospitals
  • Radiation Therapy Centers
  • Cancer Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Image Guided Radiotherapy Market, By Product

  • 5.1 Introduction
  • 5.2 Software
    • 5.2.1 Treatment Planning Software
    • 5.2.2 Image Processing Software
    • 5.2.3 Image Registration Software
    • 5.2.4 Treatment Delivery Software
    • 5.2.5 Quality Assurance Software
  • 5.3 Hardware
    • 5.3.1 Linear Accelerators (LINAC)
    • 5.3.2 X-ray Systems
    • 5.3.3 Ultrasound Systems
  • 5.4 Accessories
    • 5.4.1 IGRT Tables
    • 5.4.2 IGRT Couches
    • 5.4.3 IGRT Markers
    • 5.4.4 IGRT Calibrators
    • 5.4.5 IGRT Immobilization Devices
  • 5.5 Service
    • 5.5.1 Installation Services
    • 5.5.2 Maintenance and Repair Services

6 Global Image Guided Radiotherapy Market, By Technology

  • 6.1 Introduction
  • 6.2 Cone Beam Computed Tomography (CBCT)
  • 6.3 3D Ultrasound
  • 6.4 MRI-guided Radiation Therapy (MRI-RT)
  • 6.5 Positron Emission Tomography (PET) -guided Radiation Therapy (PET-RT)
  • 6.6 Computed Tomography (CT) -guided Radiation Therapy (CT-RT)
  • 6.7 Other Technologies

7 Global Image Guided Radiotherapy Market, By Application

  • 7.1 Introduction
  • 7.2 Prostate Cancer
  • 7.3 Breast Cancer
  • 7.4 Lung Cancer
  • 7.5 Head and Neck Cancer
  • 7.6 Brain Tumours
  • 7.7 Gynaecological Cancer
  • 7.8 Other Applications

8 Global Image Guided Radiotherapy Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Radiation Therapy Centers
  • 8.4 Cancer Research Institutes
  • 8.5 Other End Users

9 Global Image Guided Radiotherapy Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Siemens Healthineers
  • 11.2 Elekta AB
  • 11.3 Accuray Incorporated
  • 11.4 ViewRay, Inc.
  • 11.5 Brainlab AG
  • 11.6 RaySearch Laboratories
  • 11.7 Mevion Medical Systems
  • 11.8 C-RAD AB
  • 11.9 IBA Dosimetry GmbH
  • 11.10 Philips Healthcare
  • 11.11 Hitachi Medical Systems
  • 11.12 Theragenics Corporation
  • 11.13 Nanobiotix
  • 11.14 Xstrahl Limited

List of Tables

  • Table 1 Global Image Guided Radiotherapy Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Image Guided Radiotherapy Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Image Guided Radiotherapy Market Outlook, By Software (2021-2030) ($MN)
  • Table 4 Global Image Guided Radiotherapy Market Outlook, By Treatment Planning Software (2021-2030) ($MN)
  • Table 5 Global Image Guided Radiotherapy Market Outlook, By Image Processing Software (2021-2030) ($MN)
  • Table 6 Global Image Guided Radiotherapy Market Outlook, By Image Registration Software (2021-2030) ($MN)
  • Table 7 Global Image Guided Radiotherapy Market Outlook, By Treatment Delivery Software (2021-2030) ($MN)
  • Table 8 Global Image Guided Radiotherapy Market Outlook, By Quality Assurance Software (2021-2030) ($MN)
  • Table 9 Global Image Guided Radiotherapy Market Outlook, By Hardware (2021-2030) ($MN)
  • Table 10 Global Image Guided Radiotherapy Market Outlook, By Linear Accelerators (LINAC) (2021-2030) ($MN)
  • Table 11 Global Image Guided Radiotherapy Market Outlook, By X-ray Systems (2021-2030) ($MN)
  • Table 12 Global Image Guided Radiotherapy Market Outlook, By Ultrasound Systems (2021-2030) ($MN)
  • Table 13 Global Image Guided Radiotherapy Market Outlook, By Accessories (2021-2030) ($MN)
  • Table 14 Global Image Guided Radiotherapy Market Outlook, By IGRT Tables (2021-2030) ($MN)
  • Table 15 Global Image Guided Radiotherapy Market Outlook, By IGRT Couches (2021-2030) ($MN)
  • Table 16 Global Image Guided Radiotherapy Market Outlook, By IGRT Markers (2021-2030) ($MN)
  • Table 17 Global Image Guided Radiotherapy Market Outlook, By IGRT Calibrators (2021-2030) ($MN)
  • Table 18 Global Image Guided Radiotherapy Market Outlook, By IGRT Immobilization Devices (2021-2030) ($MN)
  • Table 19 Global Image Guided Radiotherapy Market Outlook, By Service (2021-2030) ($MN)
  • Table 20 Global Image Guided Radiotherapy Market Outlook, By Installation Services (2021-2030) ($MN)
  • Table 21 Global Image Guided Radiotherapy Market Outlook, By Maintenance and Repair Services (2021-2030) ($MN)
  • Table 22 Global Image Guided Radiotherapy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 23 Global Image Guided Radiotherapy Market Outlook, By Cone Beam Computed Tomography (CBCT) (2021-2030) ($MN)
  • Table 24 Global Image Guided Radiotherapy Market Outlook, By 3D Ultrasound (2021-2030) ($MN)
  • Table 25 Global Image Guided Radiotherapy Market Outlook, By MRI-guided Radiation Therapy (MRI-RT) (2021-2030) ($MN)
  • Table 26 Global Image Guided Radiotherapy Market Outlook, By Positron Emission Tomography (PET) -guided Radiation Therapy (PET-RT) (2021-2030) ($MN)
  • Table 27 Global Image Guided Radiotherapy Market Outlook, By Computed Tomography (CT) -guided Radiation Therapy (CT-RT) (2021-2030) ($MN)
  • Table 28 Global Image Guided Radiotherapy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 29 Global Image Guided Radiotherapy Market Outlook, By Application (2021-2030) ($MN)
  • Table 30 Global Image Guided Radiotherapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
  • Table 31 Global Image Guided Radiotherapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
  • Table 32 Global Image Guided Radiotherapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
  • Table 33 Global Image Guided Radiotherapy Market Outlook, By Head and Neck Cancer (2021-2030) ($MN)
  • Table 34 Global Image Guided Radiotherapy Market Outlook, By Brain Tumours (2021-2030) ($MN)
  • Table 35 Global Image Guided Radiotherapy Market Outlook, By Gynaecological Cancer (2021-2030) ($MN)
  • Table 36 Global Image Guided Radiotherapy Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 37 Global Image Guided Radiotherapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 38 Global Image Guided Radiotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 39 Global Image Guided Radiotherapy Market Outlook, By Radiation Therapy Centers (2021-2030) ($MN)
  • Table 40 Global Image Guided Radiotherapy Market Outlook, By Cancer Research Institutes (2021-2030) ($MN)
  • Table 41 Global Image Guided Radiotherapy Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.